Study email invitation

Attachment 4: Study email invitation

Subject Line: Pharmacy Harm Reduction Study Orientation: You are Invited 

Hello (insert potential participant’s name), 

Your manager (insert pharmacy manager’s name) gave us permission to contact you and other staff at (insert name of pharmacy) to inform you of an opportunity to take part in an approved study at your pharmacy. The study is funded by the Centers for Disease Control and Prevention (CDC #75D30120C09651). Participation in the study is completely voluntary. 

The study aims to learn about pharmacy-based non-prescription syringe sales practices - what is currently being done and how effective short training videos can be to support pharmacies and staff engaged in non-prescription syringe sales. 

In order to share information and answer your questions about the study and what participation in the study would mean for you, we are holding two live, remote orientation sessions: 

• Zoom Session 1 (30-45 minutes) - (insert date) - Register to attend here (insert registration link) 

• Zoom Session 2 (30-45 minutes) - (insert date) - Register to attend here (insert registration link) 

Those interested in attending an orientation session who cannot make either of these sessions can access the recorded meeting at (insert link). 

After the orientation sessions, attendees will be emailed information and a consent form in order to enroll in the study if they chose to do so.  Please remember that participation is voluntary and your involvement in the orientation or study has no bearing at all on your employment. 

If you have questions, please let us know. 

Thank you very much, 

Lane Edwards, MPH               Tamara Kuhn, MA                   Regina Firpo-Triplett, MPH                 

Project Director                       Principal Investigator             Principal Investigator